Pixie Dust Technologies commercializes technologies derived from University of Tsukuba research that control waves for applications in healthcare and spatial acoustics. Its healthcare products include the ultrasonic scalp-care device SonoRepro and the gamma-wave sound care device kikippa, while its spatial and acoustics offerings include communication tools for the hearing impaired such as VUEVO and VUEVO Display. The company reports over nine years of activity, during which it has pursued more than 108 R&D themes and filed 238 domestic and 38 international patent applications, with 43 domestic and 5 international patent registrations. Pixie Dust says it will use the new funding to expand sales channels, grow its customer base, continue R&D, develop new products, pursue global expansion, and repay interest-bearing debt. With this financing the company intends to move from R&D and development phases into a full business expansion phase and accelerate growth.

Total raised

$21M

Funding rounds

2

Latest round

Series D

Latest activity

May 2026